Oruka Therapeutics ORKA Holds Steady Near Resistance as Traders Eye Key Levels Universal Music Group Rejects Pershing Squares Takeover Bid as Undervaluing the Company Boston Omaha Q4 2025 Earnings Significant EPS Disappointment Amid Elevated Costs Nio Shares Surge After Launch of First Flagship SUV in Over Two Years